共查询到20条相似文献,搜索用时 62 毫秒
1.
Jason D. Hoffert Chung-Lin Chou Mark A. Knepper 《The Journal of biological chemistry》2009,284(22):14683-14687
Vasopressin controls renal water excretion largely through actions to
regulate the water channel aquaporin-2 in collecting duct principal cells. Our
knowledge of the mechanisms involved has increased markedly in recent years
with the advent of methods for large-scale systems-level profiling such as
protein mass spectrometry, yeast two-hybrid analysis, and oligonucleotide
microarrays. Here we review this progress.Regulation of water excretion by the kidney is one of the most visible
aspects of everyday physiology. An outdoor tennis game on a hot summer day can
result in substantial water losses by sweating, and the kidneys respond by
reducing water excretion. In contrast, excessive intake of water, a frequent
occurrence in everyday life, results in excretion of copious amounts of clear
urine. These responses serve to exact tight control on the tonicity of body
fluids, maintaining serum osmolality in the range of 290–294 mosmol/kg
of H2O through the regulated return of water from the pro-urine in
the renal collecting ducts to the bloodstream.The importance of this process is highlighted when the regulation fails.
For example, polyuria (rapid uncontrolled excretion of water) is a sometimes
devastating consequence of lithium therapy for bipolar disorder. On the other
side of the coin are water balance disorders that result from excessive renal
water retention causing systemic hypo-osmolality or hyponatremia. Hyponatremia
due to excessive water retention can be seen with severe congestive heart
failure, hepatic cirrhosis, and the syndrome of inappropriate
antidiuresis.The chief regulator of water excretion is the peptide hormone
AVP,2 whereas the
chief molecular target for regulation is the water channel AQP2. In this
minireview, we describe new progress in the understanding of the molecular
mechanisms involved in regulation of AQP2 by AVP in collecting duct cells,
with emphasis on new information derived from “systems-level”
approaches involving large-scale profiling and screening techniques such as
oligonucleotide arrays, protein mass spectrometry, and yeast two-hybrid
analysis. Most of the progress with these techniques is in the identification
of individual molecules involved in AVP signaling and binding interactions
with AQP2. Additional related issues are addressed in several recent reviews
(1–4). 相似文献
2.
3.
4.
5.
Yuya Sato Tomoya Isaji Michiko Tajiri Shumi Yoshida-Yamamoto Tsuyoshi Yoshinaka Toshiaki Somehara Tomohiko Fukuda Yoshinao Wada Jianguo Gu 《The Journal of biological chemistry》2009,284(18):11873-11881
Recently we reported that N-glycans on the β-propeller domain
of the integrin α5 subunit (S-3,4,5) are essential for α5β1
heterodimerization, expression, and cell adhesion. Herein to further
investigate which N-glycosylation site is the most important for the
biological function and regulation, we characterized the S-3,4,5 mutants in
detail. We found that site-4 is a key site that can be specifically modified
by N-acetylglucosaminyltransferase III (GnT-III). The introduction of
bisecting GlcNAc into the S-3,4,5 mutant catalyzed by GnT-III decreased cell
adhesion and migration on fibronectin, whereas overexpression of
N-acetylglucosaminyltransferase V (GnT-V) promoted cell migration.
The phenomenon is similar to previous observations that the functions of the
wild-type α5 subunit were positively and negatively regulated by GnT-V
and GnT-III, respectively, suggesting that the α5 subunit could be
duplicated by the S-3,4,5 mutant. Interestingly GnT-III specifically modified
the S-4,5 mutant but not the S-3,5 mutant. This result was confirmed by
erythroagglutinating phytohemagglutinin lectin blot analysis. The reduction in
cell adhesion was consistently observed in the S-4,5 mutant but not in the
S-3,5 mutant cells. Furthermore mutation of site-4 alone resulted in a
substantial decrease in erythroagglutinating phytohemagglutinin lectin
staining and suppression of cell spread induced by GnT-III compared with that
of either the site-3 single mutant or wild-type α5. These results, taken
together, strongly suggest that N-glycosylation of site-4 on the
α5 subunit is the most important site for its biological functions. To
our knowledge, this is the first demonstration that site-specific modification
of N-glycans by a glycosyltransferase results in functional
regulation.Glycosylation is a crucial post-translational modification of most secreted
and cell surface proteins (1).
Glycosylation is involved in a variety of physiological and pathological
events, including cell growth, migration, differentiation, and tumor invasion.
It is well known that glycans play important roles in cell-cell communication,
intracellular signal transduction, protein folding, and stability
(2,
3).Integrins comprise a family of receptors that are important for cell
adhesion. The major function of integrins is to connect cells to the
extracellular matrix, activate intracellular signaling pathways, and regulate
cytoskeletal formation (4).
Integrin α5β1 is well known as a fibronectin
(FN)3 receptor. The
interaction between integrin α5 and FN is essential for cell migration,
cell survival, and development
(5–8).
In addition, integrins are N-glycan carrier proteins. For example,
α5β1 integrin contains 14 and 12 putative N-glycosylation
sites on the α5 and β1 subunits, respectively. Several studies
suggest that N-glycosylation is essential for functional integrin
α5β1. When human fibroblasts were cultured in the presence of
1-deoxymannojirimycin, which prevents N-linked oligosaccharide
processing, immature α5β1 integrin appeared on the cell surface,
and FN-dependent adhesion was greatly reduced
(9). Treatment of purified
integrin α5β1 with N-glycosidase F, which cleaves between
the innermost N-acetylglucosamine (GlcNAc) and asparagine
N-glycan residues of N-linked glycoproteins, prevented the
inherent association between subunits and blocked α5β1 binding to
FN (10).A growing body of evidence indicates that the presence of the appropriate
oligosaccharide can modulate integrin activation.
N-Acetylglucosaminyltransferase III (GnT-III) catalyzes the addition
of GlcNAc to mannose that is β1,4-linked to an underlying
N-acetylglucosamine, producing what is known as a
“bisecting” GlcNAc linkage as shown in
Fig. 1B. GnT-III is
generally regarded as a key glycosyltransferase in N-glycan
biosynthetic pathways and contributes to inhibition of metastasis. The
introduction of a bisecting GlcNAc catalyzed by GnT-III suppresses additional
processing and elongation of N-glycans. These reactions, which are
catalyzed in vitro by other glycosyltransferases, such as
N-acetylglucosaminyltransferase V (GnT-V), which catalyzes the
formation of β1,6 GlcNAc branching structures
(Fig. 1B) and plays
important roles in tumor metastasis, do not proceed because the enzymes cannot
utilize the bisected N-glycans as a substrate. Introduction of the
bisecting GlcNAc to integrin α5 by overexpression of GnT-III resulted in
decreased in ligand binding and down-regulation of cell adhesion and migration
(11–13).
Contrary to the functions of GnT-III, overexpression of GnT-V promoted
integrin α5β1-mediated cell migration on FN
(14). These observations
clearly demonstrate that the alteration of N-glycan structure
affected the biological functions of integrin α5β1. Similarly
characterization of the carbohydrate moieties in integrin α3β1 from
non-metastatic and metastatic human melanoma cell lines showed that expression
of β1,6 GlcNAc branched structures was higher in metastatic cells
compared with non-metastatic cells, confirming the notion that the β1,6
GlcNAc branched structure confers invasive and metastatic properties to cancer
cells. In fact, Partridge et al.
(15) reported that
GnT-V-modified N-glycans containing
poly-N-acetyllactosamine, the preferred ligand for galectin-3, on
surface receptors oppose their constitutive endocytosis, promoting
intracellular signaling and consequently cell migration and tumor
metastasis.Open in a separate windowFIGURE 1.Potential N-glycosylation sites on the α5 subunit and its
modification by GnT-III and GnT-V. A, schematic diagram of
potential N-glycosylation sites on the α5 subunit. Putative
N-glycosylation sites are indicated by triangles, and point
mutations are indicated by crosses (N84Q, N182Q, N297Q, N307Q, N316Q,
N524Q, N530Q, N593Q, N609Q, N675Q, N712Q, N724Q, N773Q, and N868Q).
B, illustration of the reaction catalyzed by GnT-III and GnT-V.
Square, GlcNAc; circle, mannose. TM, transmembrane
domain.In addition, sialylation on the non-reducing terminus of N-glycans
of α5β1 integrin plays an important role in cell adhesion. Colon
adenocarcinomas express elevated levels of α2,6 sialylation and
increased activity of ST6GalI sialyltransferase. Elevated ST6GalI positively
correlated with metastasis and poor survival. Therefore, ST6GalI-mediated
hypersialylation likely plays a role in colorectal tumor invasion
(16,
17). In fact, oncogenic
ras up-regulated ST6GalI and, in turn, increased sialylation of
β1 integrin adhesion receptors in colon epithelial cells
(18). However, this is not
always the case. The expression of hyposialylated integrin α5β1 was
induced by phorbol esterstimulated differentiation in myeloid cells in which
the expression of the ST6GalI was down-regulated by the treatment, increasing
FN binding (19). A similar
phenomenon was also observed in hematopoietic or other epithelial cells. In
these cells, the increased sialylation of the β1 integrin subunit was
correlated with reduced adhesiveness and metastatic potential
(20–22).
In contrast, the enzymatic removal of α2,8-linked oligosialic acids from
the α5 integrin subunit inhibited cell adhesion to FN
(23). Collectively these
findings suggest that the interaction of integrin α5β1 with FN is
dependent on its N-glycosylation and the processing status of
N-glycans.Because integrin α5β1 contains multipotential
N-glycosylation sites, it is important to determine the sites that
are crucial for its biological function and regulation. Recently we found that
N-glycans on the β-propeller domain (sites 3, 4, and 5) of the
integrin α5 subunit are essential for α5β1
heterodimerization, cell surface expression, and biological function
(24). In this study, to
further investigate the underlying molecular mechanism of GnT-III-regulated
biological functions, we characterized the N-glycans on the α5
subunit in detail using genetic and biochemical approaches and found that
site-4 is a key site that can be specifically modified by GnT-III. 相似文献
6.
7.
8.
9.
10.
Tomoya Isaji Yuya Sato Tomohiko Fukuda Jianguo Gu 《The Journal of biological chemistry》2009,284(18):12207-12216
N-Glycosylation of integrin α5β1 plays a crucial role
in cell spreading, cell migration, ligand binding, and dimer formation, but
the detailed mechanisms by which N-glycosylation mediates these
functions remain unclear. In a previous study, we showed that three potential
N-glycosylation sites (α5S3–5) on the β-propeller of
the α5 subunit are essential to the functional expression of the
subunit. In particular, site 5 (α5S5) is the most important for its
expression on the cell surface. In this study, the function of the
N-glycans on the integrin β1 subunit was investigated using
sequential site-directed mutagenesis to remove the combined putative
N-glycosylation sites. Removal of the N-glycosylation sites
on the I-like domain of the β1 subunit (i.e. the Δ4-6
mutant) decreased both the level of expression and heterodimeric formation,
resulting in inhibition of cell spreading. Interestingly, cell spreading was
observed only when the β1 subunit possessed these three
N-glycosylation sites (i.e. the S4-6 mutant). Furthermore,
the S4-6 mutant could form heterodimers with either α5S3-5 or α5S5
mutant of the α5 subunit. Taken together, the results of the present
study reveal for the first time that N-glycosylation of the I-like
domain of the β1 subunit is essential to both the heterodimer formation
and biological function of the subunit. Moreover, because the
α5S3-5/β1S4-6 mutant represents the minimal
N-glycosylation required for functional expression of the β1
subunit, it might also be useful for the study of molecular structures.Integrin is a heterodimeric glycoprotein that consists of both an α
and a β subunit (1). The
interaction between integrin and the extracellular matrix is essential to both
physiologic and pathologic events, such as cell migration, development, cell
viability, immune homeostasis, and tumorigenesis
(2,
3). Among the integrin
superfamily, β1 integrin can combine with 12 distinct α subunits
(α1–11, αv) to form heterodimers, thereby acquiring a wide
variety of ligand specificity
(1,
4). Integrins are thought to be
regulated by inside-out signaling mechanisms that provoke conformational
changes, which modulate the affinity of integrin for the ligand
(5). However, an increasing
body of evidence suggests that cell-surface carbohydrates mediate a variety of
interactions between integrin and its extracellular environment, thereby
affecting integrin activity and possibly tumor metastasis as well
(6–8).Guo et al. (9)
reported that an increase in β1–6-GlcNAc sugar chains on the
integrin β1 subunit stimulated cell migration. In addition, elevated
sialylation of the β1 subunit, because of Ras-induced STGal-I transferase
activity, also induced cell migration
(10,
11). Conversely, cell
migration and spreading were reduced by the addition of a bisecting GlcNAc,
which is a product of N-acetylglucosaminyltransferase III
(GnT-III),2 to the
α5β1 and α3β1 integrins
(12,
13). Alterations of
N-glycans on integrins might also regulate their cis interactions
with membrane-associated proteins, including the epidermal growth factor
receptor, the galectin family, and the tetraspanin family of proteins
(14–19).In addition to the positive and negative regulatory effects of
N-glycan, several research groups have reported that
N-glycans must be present on integrin α5β1 for the
αβ heterodimer formation and proper integrin-matrix interactions.
Consistent with this hypothesis, in the presence of the glycosylation
inhibitor, tunicamycin, normal integrin-substrate binding and transport to the
cell surface are inhibited
(20). Moreover, treatment of
purified integrin with N-glycosidase F blocked both the inherent
association of the subunits and the interaction between integrin and
fibronectin (FN) (21). These
results suggest that N-glycosylation is essential to the functional
expression of α5β1. However, because integrin α5β1
contains 26 potential N-linked glycosylation sites, 14 in the α
subunit and 12 in the β subunit, identification of the sites that are
essential to its biological functions is key to understanding the molecular
mechanisms by which N-glycans alter integrin function. Recently, our
group determined that N-glycosylation of the β-propeller domain
on the α5 subunit is essential to both heterodimerization and biological
functions of the subunit. Furthermore, we determined that sites 3–5 are
the most important sites for α5 subunit-mediated cell spreading and
migration on FN (22). The
purpose of this study was to clarify the roles of N-glycosylation of
the β1 subunit. Therefore, we performed combined substitutions in the
putative N-glycosylation sites by replacement of asparagine residues
with glutamine residues. We subsequently introduced these mutated genes into
β1-deficient epithelial cells (GE11). The results of these mutation
experiments revealed that the N-glycosylation sites on the I-like
domain of the β1 subunit, sites number 4–6 (S4-6), are essential to
both heterodimer formation and biological functions, such as cell
spreading. 相似文献
11.
Haihong Zong Claire C. Bastie Jun Xu Reinhard Fassler Kevin P. Campbell Irwin J. Kurland Jeffrey E. Pessin 《The Journal of biological chemistry》2009,284(7):4679-4688
Integrin receptor plays key roles in mediating both inside-out and
outside-in signaling between cells and the extracellular matrix. We have
observed that the tissue-specific loss of the integrin β1 subunit in
striated muscle results in a near complete loss of integrin β1 subunit
protein expression concomitant with a loss of talin and to a lesser extent, a
reduction in F-actin content. Muscle-specific integrin β1-deficient mice
had no significant difference in food intake, weight gain, fasting glucose,
and insulin levels with their littermate controls. However, dynamic analysis
of glucose homeostasis using euglycemichyperinsulinemic clamps demonstrated a
44 and 48% reduction of insulin-stimulated glucose infusion rate and glucose
clearance, respectively. The whole body insulin resistance resulted from a
specific inhibition of skeletal muscle glucose uptake and glycogen synthesis
without any significant effect on the insulin suppression of hepatic glucose
output or insulin-stimulated glucose uptake in adipose tissue. The reduction
in skeletal muscle insulin responsiveness occurred without any change in GLUT4
protein expression levels but was associated with an impairment of the
insulin-stimulated protein kinase B/Akt serine 473 phosphorylation but not
threonine 308. The inhibition of insulin-stimulated serine 473 phosphorylation
occurred concomitantly with a decrease in integrin-linked kinase expression
but with no change in the mTOR·Rictor·LST8 complex (mTORC2).
These data demonstrate an in vivo crucial role of integrin β1
signaling events in mediating cross-talk to that of insulin action.Integrin receptors are a large family of integral membrane proteins
composed of a single α and β subunit assembled into a heterodimeric
complex. There are 19 α and 8 β mammalian subunit isoforms that
combine to form 25 distinct α,β heterodimeric receptors
(1-5).
These receptors play multiple critical roles in conveying extracellular
signals to intracellular responses (outside-in signaling) as well as altering
extracellular matrix interactions based upon intracellular changes (inside-out
signaling). Despite the large overall number of integrin receptor complexes,
skeletal muscle integrin receptors are limited to seven α subunit
subtypes (α1, α3, α4, α5, α6, α7, and
αν subunits), all associated with the β1 integrin subunit
(6,
7).Several studies have suggested an important cross-talk between
extracellular matrix and insulin signaling. For example, engagement of β1
subunit containing integrin receptors was observed to increase
insulin-stimulated insulin receptor substrate
(IRS)2
phosphorylation, IRS-associated phosphatidylinositol 3-kinase, and activation
of protein kinase B/Akt
(8-11).
Integrin receptor regulation of focal adhesion kinase was reported to modulate
insulin stimulation of glycogen synthesis, glucose transport, and cytoskeleton
organization in cultured hepatocytes and myoblasts
(12,
13). Similarly, the
integrin-linked kinase (ILK) was suggested to function as one of several
potential upstream kinases that phosphorylate and activate Akt
(14-18).
In this regard small interfering RNA gene silencing of ILK in fibroblasts and
conditional ILK gene knockouts in macrophages resulted in a near complete
inhibition of insulin-stimulated Akt serine 473 (Ser-473) phosphorylation
concomitant with an inhibition of Akt activity and phosphorylation of Akt
downstream targets (19).
However, a complex composed of mTOR·Rictor·LST8 (termed mTORC2)
has been identified in several other studies as the Akt Ser-473 kinase
(20,
21). In addition to Ser-473,
Akt protein kinase activation also requires phosphorylation on threonine 308
Thr-30 by phosphoinositide-dependent protein kinase, PDK1
(22-24).In vivo, skeletal muscle is the primary tissue responsible for
postprandial (insulin-stimulated) glucose disposal that results from the
activation of signaling pathways leading to the translocation of the
insulin-responsive glucose transporter, GLUT4, from intracellular sites to the
cell surface membranes (25,
26). Dysregulation of any step
of this process in skeletal muscle results in a state of insulin resistance,
thereby predisposing an individual for the development of diabetes
(27-33).
Although studies described above have utilized a variety of tissue culture
cell systems to address the potential involvement of integrin receptor
signaling in insulin action, to date there has not been any investigation of
integrin function on insulin action or glucose homeostasis in vivo.
To address this issue, we have taken advantage of Cre-LoxP technology to
inactivate the β1 integrin receptor subunit gene in striated muscle. We
have observed that muscle creatine kinase-specific integrin β1 knock-out
(MCKItgβ1 KO) mice display a reduction of insulin-stimulated glucose
infusion rate and glucose clearance. The impairment of insulin-stimulated
skeletal muscle glucose uptake and glycogen synthesis resulted from a decrease
in Akt Ser-473 phosphorylation concomitant with a marked reduction in ILK
expression. Together, these data demonstrate an important cross-talk between
integrin receptor function and insulin action and suggests that ILK may
function as an Akt Ser-473 kinase in skeletal muscle. 相似文献
12.
13.
Jenny Erales Sabrina Lignon Brigitte Gontero 《The Journal of biological chemistry》2009,284(19):12735-12744
A new role is reported for CP12, a highly unfolded and flexible protein,
mainly known for its redox function with A4
glyceraldehyde-3-phosphate dehydrogenase (GAPDH). Both reduced and oxidized
CP12 can prevent the in vitro thermal inactivation and aggregation of
GAPDH from Chlamydomonas reinhardtii. This mechanism is thus not
redox-dependent. The protection is specific to CP12, because other proteins,
such as bovine serum albumin, thioredoxin, and a general chaperone, Hsp33, do
not fully prevent denaturation of GAPDH. Furthermore, CP12 acts as a specific
chaperone, since it does not protect other proteins, such as catalase, alcohol
dehydrogenase, or lysozyme. The interaction between CP12 and GAPDH is
necessary to prevent the aggregation and inactivation, since the mutant C66S
that does not form any complex with GAPDH cannot accomplish this protection.
Unlike the C66S mutant, the C23S mutant that lacks the N-terminal bridge is
partially able to protect and to slow down the inactivation and aggregation.
Tryptic digestion coupled to mass spectrometry confirmed that the S-loop of
GAPDH is the interaction site with CP12. Thus, CP12 not only has a redox
function but also behaves as a specific “chaperone-like protein”
for GAPDH, although a stable and not transitory interaction is observed. This
new function of CP12 may explain why it is also present in complexes involving
A2B2 GAPDHs that possess a regulatory C-terminal
extension (GapB subunit) and therefore do not require CP12 to be
redox-regulated.CP12 is a small 8.2-kDa protein present in the chloroplasts of most
photosynthetic organisms, including cyanobacteria
(1,
2), higher plants
(3), the diatom
Asterionella formosa
(4,
5), and green
(1) and red algae
(6). It allows the formation of
a supramolecular complex between phosphoribulokinase (EC 2.7.1.19) and
glyceraldehyde-3-phosphate dehydrogenase
(GAPDH),3 two key
enzymes of the Calvin cycle pathway, and was recently shown to interact with
fructose bisphosphate aldolase, another enzyme of the Calvin cycle pathway
(7). The
phosphoribulokinase·GAPDH·CP12 complex has been extensively
studied in Chlamydomonas reinhardtii
(8,
9) and in Arabidopsis
thaliana (10,
11). In the green alga C.
reinhardtii, the interaction between CP12 and GAPDH is strong
(8). GAPDH may exist as a
homotetramer composed of four GapA subunits (A4) in higher plants,
cyanobacteria, and green and red algae
(6,
12), but in higher plants, it
can also exist as a heterotetramer (A2B2), composed of
two subunits, GapA and GapB
(13,
14). GapB, up to now, has
exclusively been found in Streptophyta, but recently two
prasinophycean green algae, Ostreococcus tauri and Ostreococcus
lucimarinus, were also shown to possess a GapB gene, whereas
CP12 is missing (15).
The GapB subunit is similar to the GapA subunit but has a C-terminal extension
containing two redox-regulated cysteine residues
(16). Thus, although the
A4 GAPDHs lack these regulatory cysteine residues
(13,
14,
17–20),
they are also redox-regulated through its interaction with CP12, since the C
terminus of this small protein resembles the C-terminal extension of the GapB
subunit. The regulatory cysteine residues for GapA are thus supplied by CP12,
as is well documented in the literature
(1,
8,
11,
16).CP12 belongs to the family of intrinsically unstructured proteins (IUPs)
(21–26).
The amino acid composition of these proteins causes them to have no or few
secondary structures. Their total or partial lack of structure and their high
flexibility allow them to be molecular adaptors
(27,
28). They are often able to
bind to several partners and are involved in most cellular functions
(29,
30). Recently, some IUPs have
been described in photosynthetic organisms
(31,
32).There are many functional categories of IUPs
(22,
33). They can be, for
instance, involved in permanent binding and have (i) a scavenger role,
neutralizing or storing small ligands; (ii) an assembler role by forming
complexes; and (iii) an effector role by modulating the activity of a partner
molecule (33). These functions
are not exclusive; thus, CP12 can form a stable complex with GAPDH, regulating
its redox properties (8,
34,
35), and can also bind a metal
ion (36,
37). IUPs can also bind
transiently to partners, and some of them have been found to possess a
chaperone activity (31,
38). This chaperone function
was first shown for α-synuclein
(39) and for α-casein
(40), which are fully
disordered. The amino acid composition of IUPs is less hydrophobic than those
of soluble proteins; hence, they lack hydrophobic cores and do not become
insoluble when heated. Since CP12 belongs to this family, we tested if it was
resistant to heat treatment and finally, since it is tightly bound to GAPDH,
if it could prevent aggregation of its partner, GAPDH, an enzyme well known
for its tendency to aggregate
(41–44)
and consequently a substrate commonly used in chaperone studies
(45,
46).Unlike chaperones, which form transient, dynamic complexes with their
protein substrates through hydrophobic interactions
(47,
48), CP12 forms a stable
complex with GAPDH. The interaction involves the C-terminal part of the
protein and the presence of negatively charged residues on CP12
(35). However, only a
site-directed mutagenesis has been performed to characterize the interaction
site on GAPDH. Although the mutation could have an indirect effect, the
residue Arg-197 was shown to be a good candidate for the interaction site
(49).In this report, we accordingly used proteolysis experiments coupled with
mass spectrometry to detect which regions of GAPDH are protected by its
association with CP12. To conclude, the aim of this report was to characterize
a chaperone function of CP12 that had never been described before and to map
the interaction site on GAPDH using an approach that does not involve
site-directed mutagenesis. 相似文献
14.
Irmgard Paris Carolina Perez-Pastene Eduardo Couve Pablo Caviedes Susan LeDoux Juan Segura-Aguilar 《The Journal of biological chemistry》2009,284(20):13306-13315
Parkinsonism is one of the major neurological symptoms in Wilson disease,
and young workers who worked in the copper smelting industry also developed
Parkinsonism. We have reported the specific neurotoxic action of
copper·dopamine complex in neurons with dopamine uptake.
Copper·dopamine complex (100 μm) induces cell death in
RCSN-3 cells by disrupting the cellular redox state, as demonstrated by a
1.9-fold increase in oxidized glutathione levels and a 56% cell death
inhibition in the presence of 500 μm ascorbic acid; disruption
of mitochondrial membrane potential with a spherical shape and well preserved
morphology determined by transmission electron microscopy; inhibition (72%,
p < 0.001) of phosphatidylserine externalization with 5
μm cyclosporine A; lack of caspase-3 activation; formation of
autophagic vacuoles containing mitochondria after 2 h; transfection of cells
with green fluorescent protein-light chain 3 plasmid showing that 68% of cells
presented autophagosome vacuoles; colocalization of positive staining for
green fluorescent protein-light chain 3 and Rhod-2AM, a selective indicator of
mitochondrial calcium; and DNA laddering after 12-h incubation. These results
suggest that the copper·dopamine complex induces mitochondrial
autophagy followed by caspase-3-independent apoptotic cell death. However, a
different cell death mechanism was observed when 100 μm
copper·dopamine complex was incubated in the presence of 100
μm dicoumarol, an inhibitor of NAD(P)H quinone:oxidoreductase
(EC 1.6.99.2, also known as DT-diaphorase and NQ01), because a more extensive
and rapid cell death was observed. In addition, cyclosporine A had no effect
on phosphatidylserine externalization, significant portions of compact
chromatin were observed within a vacuolated nuclear membrane, DNA laddering
was less pronounced, the mitochondria morphology was more affected, and the
number of cells with autophagic vacuoles was a near 4-fold less.A possible role of copper in the neurodegeneration of dopaminergic neurons
is supported by the fact that patients with neurological Wilson disease, a
copper deposition disorder, display a number of extrapyramidal motor symptoms,
including Parkinsonism. The cerebral manifestations in neurological Wilson
disease are expressed as bradykinesia, rigidity, tremor, dyskinesia, and
dysarthria (1). It has been
proposed that neurological Wilson disease can be assigned to the group of
secondary Parkinsonian syndromes
(2). Interestingly, young
workers who worked in the copper smelting industry also developed Parkinsonism
(3).Studies performed in rats showed copper (Cu2+)-induced
degeneration of dopaminergic neurons in the nigrostriatal system. Likewise, it
was described that copper neurotoxicity in rat substantia nigra and striatum
is dependent on NAD(P)H dehydrogenase inhibition
(4,
5). All of these results
support a possible role for copper in the neurodegeneration of dopaminergic
neurons.The general mechanism of toxicity, induced by the reduced form of copper
(Cu+) catalyzing the formation of hydroxyl radicals in the presence
of hydrogen peroxide through the Fenton reaction, cannot explain the specific
degeneration of dopaminergic neurons in Parkinsonism induced in neurological
Wilson disease, or in miners working in the copper smelting industry. The
selective action of copper can be explained by the ability of copper to form a
complex with dopamine, allowing this metal to be transported by cells that
have the ability to take up dopamine
(6). This specific neurotoxic
action of copper in neurons with dopamine uptake is dependent on (i) the
ability of copper to form a complex with dopamine
(Cu·DA)2
(6,
7), (ii) uptake of Cu·DA
complex by dopamine transporters, (iii) oxidation of dopamine to aminochrome,
and (iv) one-electron reduction of aminochrome by inhibiting NAD(P)H
dehydrogenase (6). These
findings may explain the selective neurotoxic action of copper in the brain,
but they do not explain the cell death mechanism.Currently, cell death is divided into three categories: apoptosis,
autophagy, and necrosis. At the current time, only apoptosis and autophagic
cell death are generally accepted as being legitimate forms of programmed cell
death. Alternative models of cell death have therefore been proposed,
including para-apoptosis, mitotic catastrophe, oncosis, and pyroptosis
(8–12).
Necrosis is characterized mostly by the absence of caspase activation,
cytochrome c release, and DNA oligonucleosomal fragmentation.
Apoptotic cells are characterized by the formation of blebs, chromatin
condensation, DNA oligonucleosomal fragmentation, and exposure of
phosphatidylserine on the external membrane. This mode of cell death can be
dependent or independent of activation of caspases
(13). On the other hand,
autophagy can be distinguished from apoptosis by sequestration of bulk
cytoplasm and organelles in double or multimembrane autophagic vacuoles that
then fuse with the lysosomal system. Some of these described mechanisms are
related to neurological diseases such as Parkinson disease
(14,
15). Cells can use different
methods to activate their own destruction, and more than one death program may
be activated at the same time
(16,
17).The purpose of this study was to examine the Cu·DA complex-induced
cell death mechanism in RCSN-3 cells, a cell line that expresses dopamine,
norepinephrine, and serotonin transporters
(18,
19). 相似文献
15.
16.
17.
18.
Sharareh Emadi Srinath Kasturirangan Min S. Wang Philip Schulz Michael R. Sierks 《The Journal of biological chemistry》2009,284(17):11048-11058
Neuropathologic and genetics studies as well as transgenic animal models
have provided strong evidence linking misfolding and aggregation of
α-synuclein to the progression of Parkinson disease (PD) and other
related disorders. A growing body of evidence implicates various oligomeric
forms of α-synuclein as the toxic species responsible for
neurodegeneration and neuronal cell death. Although numerous different
oligomeric forms of α-synuclein have been identified in vitro,
it is not known which forms are involved in PD or how, when, and where
different forms contribute to the progression of PD. Reagents that can
interact with specific aggregate forms of α-synuclein would be very
useful not only as tools to study how different aggregate forms affect cell
function, but also as potential diagnostic and therapeutic agents for PD. Here
we show that a single chain antibody fragment (syn-10H scFv) isolated from a
phage display antibody library binds to a larger, later stage oligomeric form
of α-synuclein than a previously reported oligomeric specific scFv
isolated in our laboratory. The scFv described here inhibits aggregation of
α-synuclein in vitro, blocks extracellular
α-synuclein-induced toxicity in both undifferentiated and differentiated
human neuroblastoma cell lines (SH-SY5Y), and specifically recognizes
naturally occurring aggregates in PD but not in healthy human brain
tissue.Parkinson disease
(PD)2 is the second
most common neurodegenerative disorder of the elderly, affecting more than
500,000 people in the United States
(1), with 50,000 new cases
reported each year at an annual cost estimated at 10 billion dollars per year.
Pathologically, PD is characterized by the progressive loss of dopaminergic
neurons in the substantia nigra and formation of fibrillar cytoplasmic
inclusions known as Lewy bodies and Lewy neurites
(2,
3). The protein
α-synuclein has been strongly linked to PD
(4,
5) and other related
neurodegenerative disorders (6,
7) by several lines of
evidence. 1) It is the major component of the hallmark Lewy body aggregates
associated with PD. 2) Mutations (A53T, A30P, and E46K, where A30P is human
A30P α-synuclein; A53T is human A53T α-synuclein; E46K is human
E46K α-synuclein) or multiplication in the α-synuclein gene have
been linked to familial PD
(8–10).
3) Overexpression of α-synuclein in transgenic mice and
Drosophila has been shown to induce the formation of PD-like
pathological phenotypes and behavior, although the animal models do not in
general replicate neuronal loss patterns
(11,
12).α-Synuclein is a small protein (14 kDa) expressed mainly in brain
tissues and is primarily localized at the presynaptic terminals of neurons
(13). The primary structure of
α-synuclein consists of three distinct regions. The N-terminal region of
α-synuclein includes the mutation sites associated with familial PD
(A53T, A30P, and E46K) and contains six imperfectly conserved repeats (KTKEGV)
that may facilitate protein-protein binding. This repeat section is predicted
to form amphipathic α-helices, typical of the lipid-binding domain of
apolipoproteins (14). The
central region, non-amyloid component, is extremely hydrophobic and includes a
12-residue stretch (VTGVTAVAQKTV) that is essential for aggregation
(15). The C-terminal region is
enriched with acidic glutamate and aspartate residues and is responsible for
the chaperone function of α-synuclein
(16).α-Synuclein normally exists as an unfolded protein, but it can adopt
several different folded conformations depending on the environment, including
small aggregates or oligomers, spherical and linear protofibrils, as well as
the fibrillar structure found in Lewy bodies
(14,
15). A growing body of
evidence implicates the oligomeric forms of α-synuclein as the toxic
species responsible for neurodegeneration and neuronal cell death
(16–18).
Several different oligomeric forms of α-synuclein including spherical,
annular (19), pore-like
(20), and dopamine-stabilized
structures have been identified in vitro
(21).α-Synuclein is considered a cytosolic protein, and consequently its
pathogenic effect was assumed to be limited to the cytoplasm of single cells.
However, recent studies have suggested that α-synuclein also has
extracellular pathogenic effects
(22–25).
α-Synuclein was detected in blood plasma and cerebrospinal fluid in both
monomeric and oligomeric forms
(22–25),
and the presence of significantly elevated levels of oligomeric species of
α-synuclein has been reported extracellularly in plasma and
cerebrospinal fluid samples from patients with PD
(23). Furthermore, various
studies have shown that aggregated α-synuclein added extracellularly to
the culture medium is cytotoxic
(26–32).Despite all these studies, it is still not clear how the various aggregate
forms of α-synuclein are involved in the progression of PD. Therefore,
reagents that can interact with specific aggregate forms of α-synuclein
would be very useful not only for fundamental studies of how α-synuclein
aggregates affect cell function but also as potential diagnostic and
therapeutic agents for PD.Recently, we reported inhibition of both aggregation and extracellular
toxicity of α-synuclein in vitro by a single chain variable
domain antibody fragment (scFv) that specifically recognized an oligomeric
form of α-synuclein
(32). In this study, we
describe a second scFv (syn-10H) that binds a larger later stage oligomeric
form of α-synuclein than the previously reported scFv. The syn-10H scFv
neutralizes α-synuclein-induced toxicity in both undifferentiated and
differentiated SH-SY5Y human neuroblastoma cell line and inhibits
α-synuclein aggregation in vitro. The syn-10H scFv reacts
specifically with homogenized PD brain tissue but does not cross-react with
similarly treated samples taken from Alzheimer disease (AD) or healthy brain
samples. Such scFvs therefore have potential value as diagnostic reagents to
identify the presence of specific oligomeric species in PD tissue and fluid
samples. The scFvs also have value as therapeutic agents as they can be used
either extracellularly or expressed intracellularly (intrabodies) to prevent
formation of toxic aggregates in vivo whether inside or outside of
cells. Intrabodies have been used efficiently to neutralize toxic effects of
different pathogenic agents, including α-synuclein
(33–36).
Moreover, immunization studies in mouse models of PD have shown that
extracellular antibodies can reduce accumulation of intracellular aggregates
of α-synuclein (37),
thereby providing precedent for the use of scFvs in potential passive
vaccination strategies for treating PD. 相似文献
19.
Sharadrao M. Patil Shihao Xu Sarah R. Sheftic Andrei T. Alexandrescu 《The Journal of biological chemistry》2009,284(18):11982-11991
Amylin is an endocrine hormone that regulates metabolism. In patients
afflicted with type 2 diabetes, amylin is found in fibrillar deposits in the
pancreas. Membranes are thought to facilitate the aggregation of amylin, and
membrane-bound oligomers may be responsible for the islet β-cell toxicity
that develops during type 2 diabetes. To better understand the structural
basis for the interactions between amylin and membranes, we determined the NMR
structure of human amylin bound to SDS micelles. The first four residues in
the structure are constrained to form a hairpin loop by the single disulfide
bond in amylin. The last nine residues near the C terminus are unfolded. The
core of the structure is an α-helix that runs from about residues
5–28. A distortion or kink near residues 18–22 introduces pliancy
in the angle between the N- and C-terminal segments of the α-helix.
Mobility, as determined by 15N relaxation experiments, increases
from the N to the C terminus and is strongly correlated with the accessibility
of the polypeptide to spin probes in the solution phase. The spin probe data
suggest that the segment between residues 5 and 17 is positioned within the
hydrophobic lipid environment, whereas the amyloidogenic segment between
residues 20 and 29 is at the interface between the lipid and solvent. This
orientation may direct the aggregation of amylin on membranes, whereas
coupling between the two segments may mediate the transition to a toxic
structure.Type 2 diabetes affects over 100 million people worldwide
(1) and is thought to cost
upward of $130 billion dollars a year to treat in the United States alone
(2). The endocrine hormone
amylin (also known as islet amyloid polypeptide) appears to have key roles in
diabetes pathology
(3–5).
The normal functions of amylin include the inhibition of glucagon secretion,
slowing down the emptying of the stomach, and inducing a feeling of satiety
through the actions of the hormone on neurons of the hypothalamus in the brain
(5). The effects of amylin are
exerted in concert with those of insulin and reduce the level of glucose in
the blood (3,
5). Circulating amylin levels
increase in a number of pathological conditions, including obesity, syndrome
X, pancreatic cancer, and renal failure
(3). Amylin levels together
with insulin are raised initially in type 2 diabetes but fall as the disease
progresses to a stage where the pancreatic islets of Langerhans β-cells
that synthesize amylin no longer function
(3).One of the hallmarks of type 2 diabetes, found in 90% of patients, is the
formation of extracellular amyloid aggregates composed of amylin
(3–5).
The amyloid deposits accumulate in the interstitial fluid between islet cells
and are usually juxtaposed with the β-cell membranes
(3). Aggregates of amylin are
toxic when added to cultures of β-cells, so that the amyloid found in
situ may be responsible for β-cell death as type 2 diabetes
progresses (6,
7). Genetic evidence that
amylin is directly involved in pathology includes a familial S20G mutation
that leads to early onset of the disease
(8) and produces an amylin
variant that aggregates more readily
(9).As with all amyloids it is unclear whether fibrillar structures or soluble
oligomers are responsible for pathology. A recurrent theme for amyloidogenic
proteins is that toxicity appears to be exerted through membrane-bound
oligomers that form pores and disrupt ion balance across membranes
(4,
10–13).
Experimental evidence for such oligomers has been found for the amyloid-β
(Aβ)2 peptides
(14), which cause Alzheimer
disease, and for α-synuclein (αS), the protein involved in
Parkinson disease (15), a
particular interest of our laboratory. The similar toxic effects exerted by
these amyloidogenic molecules may have a common structural and physical basis.
Detailed structural models are available for Aβ
(16) and αS
(17) bound to SDS micelle
mimetics of membranes. For amylin there are models of peptide fragments
1–19 (18), 20–29
(19), and 17–29
(20) bound to micelles but as
of yet no model of the complete hormone. This turns out to be particularly
important as the interplay between structure and dynamics in amylin only comes
to light when considering the whole molecule.Here we report the solution structure of human amylin bound to SDS
micelles. We complement the structure with information on dynamics and on the
immersion of amylin into micelles. 相似文献
20.
Johann Schredelseker Anamika Dayal Thorsten Schwerte Clara Franzini-Armstrong Manfred Grabner 《The Journal of biological chemistry》2009,284(2):1242-1251
The paralyzed zebrafish strain relaxed carries a null mutation for
the skeletal muscle dihydropyridine receptor (DHPR) β1a
subunit. Lack of β1a results in (i) reduced membrane
expression of the pore forming DHPR α1S subunit, (ii)
elimination of α1S charge movement, and (iii) impediment of
arrangement of the DHPRs in groups of four (tetrads) opposing the ryanodine
receptor (RyR1), a structural prerequisite for skeletal muscle-type
excitation-contraction (EC) coupling. In this study we used relaxed
larvae and isolated myotubes as expression systems to discriminate specific
functions of β1a from rather general functions of β
isoforms. Zebrafish and mammalian β1a subunits quantitatively
restored α1S triad targeting and charge movement as well as
intracellular Ca2+ release, allowed arrangement of DHPRs in
tetrads, and most strikingly recovered a fully motile phenotype in
relaxed larvae. Interestingly, the cardiac/neuronal
β2a as the phylogenetically closest, and the ancestral
housefly βM as the most distant isoform to β1a
also completely recovered α1S triad expression and charge
movement. However, both revealed drastically impaired intracellular
Ca2+ transients and very limited tetrad formation compared with
β1a. Consequently, larval motility was either only partially
restored (β2a-injected larvae) or not restored at all
(βM). Thus, our results indicate that triad expression and
facilitation of 1,4-dihydropyridine receptor (DHPR) charge movement are common
features of all tested β subunits, whereas the efficient arrangement of
DHPRs in tetrads and thus intact DHPR-RyR1 coupling is only promoted by the
β1a isoform. Consequently, we postulate a model that presents
β1a as an allosteric modifier of α1S
conformation enabling skeletal muscle-type EC coupling.Excitation-contraction
(EC)3 coupling in
skeletal muscle is critically dependent on the close interaction of two
distinct Ca2+ channels. Membrane depolarizations of the myotube are
sensed by the voltage-dependent 1,4-dihydropyridine receptor (DHPR) in the
sarcolemma, leading to a rearrangement of charged amino acids (charge
movement) in the transmembrane segments S4 of the pore-forming DHPR
α1S subunit
(1,
2). This conformational change
induces via protein-protein interaction
(3,
4) the opening of the
sarcoplasmic type-1 ryanodine receptor (RyR1) without need of Ca2+
influx through the DHPR (5).
The release of Ca2+ from the sarcoplasmic reticulum via RyR1
consequently induces muscle contraction. The protein-protein interaction
mechanism between DHPR and RyR1 requires correct ultrastructural targeting of
both channels. In Ca2+ release units (triads and peripheral
couplings) of the skeletal muscle, groups of four DHPRs (tetrads) are coupled
to every other RyR1 and hence are geometrically arranged following the
RyR-specific orthogonal arrays
(6).The skeletal muscle DHPR is a heteromultimeric protein complex, composed of
the voltage-sensing and pore-forming α1S subunit and
auxiliary subunits β1a, α2δ-1, and
γ1 (7). While
gene knock-out of the DHPR γ1 subunit
(8,
9) and small interfering RNA
knockdown of the DHPR α2δ-1 subunit
(10-12)
have indicated that neither subunit is essential for coupling of the DHPR with
RyR1, the lack of the α1S or of the intracellular
β1a subunit is incompatible with EC coupling and accordingly
null model mice die perinatally due to asphyxia
(13,
14). β subunits of
voltage-gated Ca2+ channels were repeatedly shown to be responsible
for the facilitation of α1 membrane insertion and to be
potent modulators of α1 current kinetics and voltage
dependence (15,
16). Whether the loss of EC
coupling in β1-null mice was caused by decreased DHPR membrane
expression or by the lack of a putative specific contribution of the β
subunit to the skeletal muscle EC coupling apparatus
(17,
18) was not clearly resolved.
Recently, other β-functions were identified in skeletal muscle using the
β1-null mutant zebrafish relaxed
(19,
20). Like the
β1-knock-out mouse
(14) zebrafish
relaxed is characterized by complete paralysis of skeletal muscle
(21,
22). While
β1-knock-out mouse pups die immediately after birth due to
respiratory paralysis (14),
larvae of relaxed are able to survive for several days because of
oxygen and metabolite diffusion via the skin
(23). Using highly
differentiated myotubes that are easy to isolate from these larvae, the lack
of EC coupling could be described by quantitative immunocytochemistry as a
moderate ∼50% reduction of α1S membrane expression
although α1S charge movement was nearly absent, and, most
strikingly, as the complete lack of the arrangement of DHPRs in tetrads
(19). Thus, in skeletal muscle
the β subunit enables EC coupling by (i) enhancing α1S
membrane targeting, (ii) facilitating α1S charge movement,
and (iii) enabling the ultrastructural arrangement of DHPRs in tetrads.The question arises, which of these functions are specific for the skeletal
muscle β1a and which ones are rather general properties of
Ca2+ channel β subunits. Previous reconstitution studies made
in the β1-null mouse system
(24,
25) using different β
subunit constructs (26) did
not allow differentiation between β-induced enhancement of non-functional
α1S membrane expression and the facilitation of
α1S charge movement, due to the lack of information on
α1S triad expression levels. Furthermore, the β-induced
arrangement of DHPRs in tetrads was not detected as no ultrastructural
information was obtained.In the present study, we established zebrafish mutant relaxed as
an expression system to test different β subunits for their ability to
restore skeletal muscle EC coupling. Using isolated myotubes for in
vitro experiments (19,
27) and complete larvae for
in vivo expression studies
(28-31)
and freeze-fracture electron microscopy, a clear differentiation between the
major functional roles of β subunits was feasible in the zebrafish
system. The cloned zebrafish β1a and a mammalian (rabbit)
β1a were shown to completely restore all parameters of EC
coupling when expressed in relaxed myotubes and larvae. However, the
phylogenetically closest β subunit to β1a, the
cardiac/neuronal isoform β2a from rat, as well as the
ancestral βM isoform from the housefly (Musca
domestica), could recover functional α1S membrane
insertion, but led to very restricted tetrad formation when compared with
β1a, and thus to impaired DHPR-RyR1 coupling. This impairment
caused drastic changes in skeletal muscle function.The present study shows that the enhancement of functional
α1S membrane expression is a common function of all the
tested β subunits, from β1a to even the most distant
βM, whereas the effective formation of tetrads and thus proper
skeletal muscle EC coupling is an exclusive function of the skeletal muscle
β1a subunit. In context with previous studies, our results
suggest a model according to which β1a acts as an allosteric
modifier of α1S conformation. Only in the presence of
β1a, the α1S subunit is properly folded to
allow RyR1 anchoring and thus skeletal muscle-type EC coupling. 相似文献